Thursday 03 Jul, 2025 02:34 PM
Site map | Locate Us | Login
   REC Ltd down for fifth straight session    Persistent Systems appoints Shimona Chadha as CMO    Nazara Technologies Ltd rises for third consecutive session    Maruti Suzuki India Ltd gains for third straight session    Biocon Ltd spurts 1.07%, gains for fifth straight session    Colgate-Palmolive (India) Ltd spurts 1.01%, gains for five straight sessions    IDFC First Bank Ltd spurts 0.36%, gains for fifth straight session    BSE SME Ace Alpha Tech cracks open the trading floor on debut    BSE SME Valencia India sees chilly check-in on debut    Shakti Pumps India launches QIP with floor price of Rs 965.96/share    NBCC inks MoU with NFDC for redevelopment project under I&B Ministry    NSE SME PRO FX Tech strikes a chord with investors    NSE SME Moving Media Entertainment makes a starry market debut    CSB Bank rises after gross advances jump 32% YoY in Q1 FY26; deposits at Rs 35,990 crore    Delphi World Money Ltd leads gainers in 'B' group 
Saravan Stocks
       
Company News
Balaxi Pharmaceuticals Ltd
Balaxi Pharmaceuticals consolidated net profit declines 20.95% in the March 2025 quarter
May 31,2025   Hrs IST

Net profit of Balaxi Pharmaceuticals declined 20.95% to Rs 8.64 crore in the quarter ended March 2025 as against Rs 10.93 crore during the previous quarter ended March 2024. Sales rose 27.48% to Rs 76.27 crore in the quarter ended March 2025 as against Rs 59.83 crore during the previous quarter ended March 2024.

For the full year,net profit declined 30.19% to Rs 25.07 crore in the year ended March 2025 as against Rs 35.91 crore during the previous year ended March 2024. Sales rose 21.25% to Rs 292.56 crore in the year ended March 2025 as against Rs 241.29 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales76.2759.83 27 292.56241.29 21
OPM %16.4522.51 -12.7219.37 -
PBDT10.1211.07 -9 30.5642.41 -28
PBT9.6610.40 -7 28.6740.31 -29
NP8.6410.93 -21 25.0735.91 -30

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 42381954
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited